Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial

Overview of attention for article published in Frontiers in Clinical Diabetes and Healthcare, March 2022

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 23 X posts from 18 X users, with an upper bound of 64,302 followers.

RT @P_Rossing: Interesting how liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. from the LIRAFLAME Randomized Placebo-controlled…

LIRAFLAME

Interesting how liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. from the LIRAFLAME Randomized Placebo-controlled study… https://t.co/iWaca3Lp67 @Stenodiabetes @StenoOmics https://t.co/UIe3LuSQIt

RT @DrLegidoQuigley: New manuscript by our lab 🎉Led by the brilliant @massspectacles using #omics for mechanism discovery in clinical trial…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 19 additional X posts.